Conference Reports for NATAP

The Liver Meeting Boston MA November 2019 Back

Tropifexor (TXR), an FXR Agonist for the Treatment of NASH - Interim Results from First Two Parts of Phase 2b Study FLIGHT-FXR       Reported by Jules Levin AASLD 2018 Nov 9-13 SF